-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Qiagen, Raises Price Target to $50

Benzinga·11/13/2026 16:49:02
UBS analyst Dan Leonard maintains Qiagen (NYSE:QGEN) with a Neutral and raises the price target from $48 to $50.